Preferred Label : protease inhibitors;
MeSH definition : Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).;
MeSH synonym : endopeptidase inhibitors; protease inhibitor; peptide hydrolase inhibitors; hydrolase inhibitors, peptide; peptide peptidohydrolase inhibitors; inhibitors, peptide peptidohydrolase; peptidohydrolase inhibitors, peptide; antagonists, protease; antiproteases; inhibitors, peptidase; inhibitor, protease; inhibitors, endopeptidase; inhibitors, protease; peptidase inhibitors; protease antagonists; inhibitors, peptide hydrolase; Antiprotease; Endopeptidase Inhibitor; Inhibitor, Endopeptidase; Peptidase Inhibitor; Inhibitor, Peptidase; Peptide Hydrolase Inhibitor; Hydrolase Inhibitor, Peptide; Inhibitor, Peptide Hydrolase; Protease Antagonist; Antagonist, Protease; Peptide Peptidohydrolase Inhibitor; Inhibitor, Peptide Peptidohydrolase; Peptidohydrolase Inhibitor, Peptide;
MeSH annotation : PROTEASE INHIBITORY PROTEINS, SECRETORY is also available; DF: PROTEASE INHIB; PROTEASE INHIBITORY PROTEINS, SECRETORY is also available;
Wikipedia link : https://en.wikipedia.org/wiki/Protease inhibitors;
Is substance : O;
action pharmacologique : O;
Origin ID : D011480;
UMLS CUI : C0033607;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
False automatic mappings
Indexing information
- AG1801 [MeSH Supplementary Concept]
- AGL2019 [MeSH Supplementary Concept]
- BB 1268 [MeSH Supplementary Concept]
- SL 327 [MeSH Supplementary Concept]
- bdellin [MeSH Supplementary Concept]
- trielin [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
MeSH Descriptor(s) used for indexing
Record concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
Substance(s)
- BB 1101 [MeSH Supplementary Concept]
- GC376 [MeSH Supplementary Concept]
- ecabet [MeSH Supplementary Concept]
UMLS correspondences (same concept)
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).
https://pharmacomedicale.org/medicaments/par-specialites/item/antiviraux-utilises-dans-les-hepatites-virales
2016
false
false
false
France
French
drug information
protease inhibitors
antiviral agents
nucleic acid synthesis inhibitors
interferon-alpha
Pegylated Interferon Alfa
hepatitis B
hepatitis C
viral hepatitis
hepatitis, viral, human
antiviral agents
hepatitis
viral hepatitis, nos
hepatitis
---
http://www.infectiologie.com/UserFiles/File/medias/Recos/2013-position-societes-savantes-IPantiVHC_et_coinfection.pdf
2013
false
true
true
false
false
France
French
HIV
hepacivirus
protease inhibitors
coinfection
coinfection
liver cirrhosis
coinfection
Chronic inflammation (morphologic abnormality)
hiv infections
hepatitis C
antiretroviral therapy, highly active
HIV
withholding treatment
drug resistance
antiretroviral therapy, highly active
anemia
exanthema
drug interactions
patient education as topic
patient compliance
patient care management
ribavirin
Nucleoside Reverse Transcriptase Inhibitor
anti-retroviral agents
drug substitution
HIV-1
guidelines for drug use
---